142 related articles for article (PubMed ID: 17539937)
21. A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis.
Stefanou MI; Komorowski L; Kade S; Bornemann A; Ziemann U; Synofzik M
BMC Neurol; 2016 Sep; 16(1):172. PubMed ID: 27623618
[TBL] [Abstract][Full Text] [Related]
22. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
Skeie GO; Lunde PK; Sejersted OM; Mygland A; Aarli JA; Gilhus NE
Muscle Nerve; 1998 Mar; 21(3):329-35. PubMed ID: 9486861
[TBL] [Abstract][Full Text] [Related]
23. Pediatric myasthenia gravis with a combination of AChR and RyR is associated with an earlier onset and lower CSR rate: A cohort study in southwest China.
Liu J; Ma J; Hong S; Jiang L; Li T
Eur J Paediatr Neurol; 2023 Nov; 47():1-5. PubMed ID: 37639776
[TBL] [Abstract][Full Text] [Related]
24. Thymectomy in nonthymoma early-onset myasthenia gravis in correlation with disease severity and muscle autoantibodies.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur Neurol; 2003; 49(4):210-7. PubMed ID: 12736536
[TBL] [Abstract][Full Text] [Related]
25. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
[TBL] [Abstract][Full Text] [Related]
26. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study.
Romi F; Gilhus NE; Varhaug JE; Myking A; Aarli JA
Eur J Neurol; 2003 Nov; 10(6):701-6. PubMed ID: 14641516
[TBL] [Abstract][Full Text] [Related]
27. IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma.
Mygland A; Tysnes OB; Aarli JA; Matre R; Gilhus NE
J Autoimmun; 1993 Aug; 6(4):507-15. PubMed ID: 8216692
[TBL] [Abstract][Full Text] [Related]
28. [Determination and clinical significance of serum anti-ryanodine receptor antibody in patients with myasthenia gravis].
Cui LY; Li YF; Li YH; Zhang JB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):238-40. PubMed ID: 17536276
[TBL] [Abstract][Full Text] [Related]
29. Detection of multiple antibodies in myasthenia gravis and its clinical significance.
Wang WW; Hao HJ; Gao F
Chin Med J (Engl); 2010 Sep; 123(18):2555-8. PubMed ID: 21034627
[TBL] [Abstract][Full Text] [Related]
30. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis.
Takamori M; Motomura M; Kawaguchi N; Nemoto Y; Hattori T; Yoshikawa H; Otsuka K
Neurology; 2004 May; 62(10):1894-6. PubMed ID: 15159506
[TBL] [Abstract][Full Text] [Related]
31. Myasthenia gravis: predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan.
Iwasa K; Yoshikawa H; Samuraki M; Shinohara M; Hamaguchi T; Ono K; Nakamura H; Yamada M
J Neuroimmunol; 2014 Feb; 267(1-2):97-101. PubMed ID: 24388223
[TBL] [Abstract][Full Text] [Related]
32. Seronegative myasthenia gravis: disease severity and prognosis.
Romi F; Aarli JA; Gilhus NE
Eur J Neurol; 2005 Jun; 12(6):413-8. PubMed ID: 15885043
[TBL] [Abstract][Full Text] [Related]
33. Thymoma in myasthenia gravis: from diagnosis to treatment.
Romi F
Autoimmune Dis; 2011; 2011():474512. PubMed ID: 21860784
[TBL] [Abstract][Full Text] [Related]
34. Contribution of anti-ryanodine receptor antibody to impairment of excitation-contraction coupling in myasthenia gravis.
Imai T; Tsuda E; Hozuki T; Yoshikawa H; Yamauchi R; Saitoh M; Hisahara S; Motomura M; Kawamata J; Shimohama S
Clin Neurophysiol; 2012 Jun; 123(6):1242-7. PubMed ID: 22136737
[TBL] [Abstract][Full Text] [Related]
35. [Autoantibodies in thymoma-associated myasthenia gravis and their clinical significance].
Suzuki S
Brain Nerve; 2011 Jul; 63(7):705-12. PubMed ID: 21747140
[TBL] [Abstract][Full Text] [Related]
36. Thymectomy in the treatment of ocular myasthenia gravis.
Roberts PF; Venuta F; Rendina E; De Giacomo T; Coloni GF; Follette DM; Richman DP; Benfield JR
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):562-8. PubMed ID: 11547310
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis].
Sund KK; Skeie GO; Gilhus NE; Aarli JA; Varhaug JE
Tidsskr Nor Laegeforen; 1997 Nov; 117(29):4212-4. PubMed ID: 9441462
[TBL] [Abstract][Full Text] [Related]
38. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies.
Iwasa K; Komai K; Takamori M
Muscle Nerve; 1998 Dec; 21(12):1655-60. PubMed ID: 9843065
[TBL] [Abstract][Full Text] [Related]
40. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
